TRAF6 Activates Fibroblasts to Cancer-Associated Fibroblasts through FGF19 in Tumor Microenvironment to Benefit the Malignant Phenotype of Melanoma Cells

Yeye Guo,Xu Zhang,Weiqi Zeng,Jianglin Zhang,Lei Cai,Zeyu Wu,Juan Su,Yi Xiao,Nian Liu,Ling Tang,Xiaowei Xu,Xiang Chen,Cong Peng
DOI: https://doi.org/10.1016/j.jid.2020.03.950
IF: 7.59
2020-11-01
Journal of Investigative Dermatology
Abstract:Cancer-associated fibroblasts (CAFs) are an important component of the tumor microenvironment and mediate tumor progression in various cancers. A previous study demonstrated that TRAF6 promotes melanoma cells' malignant phenotype. However, the role of TRAF6 in melanoma CAFs remains unclear. In this study, we found that TRAF6 is significantly upregulated in CAFs adjacent to melanoma cells. Functional assays demonstrated that TRAF6 promotes fibroblast proliferation and migration as well as MMP and α-SMA expression. Moreover, the expression of TRAF6 in fibroblasts promoted the malignant phenotype of melanoma cells in vitro and in vivo. Meanwhile, the intervention of TRAF6 expression in melanoma cells affected the activation of CAFs. We found that FGF19 is a key cytokine regulated by TRAF6 through NF-κB1 using luciferase assay and chromatin immunoprecipitation in melanoma cells. Since plasma FGF19 levels are elevated in melanoma patients, it may significantly induce fibroblast activation in vitro and in vivo. Taken together, our results support that TRAF6 is a key molecule that mediates the interaction between melanoma cells and stromal fibroblasts, suggesting that TRAF6 is a potentially promising target in melanoma therapy.
dermatology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore how TRAF6 promotes the malignant phenotype of melanoma cells in the tumor microenvironment by activating fibroblasts to transform into cancer - associated fibroblasts (CAFs). Specifically, the researchers focused on the role of TRAF6 in melanoma - associated fibroblasts and how it affects the behavior of melanoma cells by regulating the expression of FGF19. ### Research Background - **Tumor Microenvironment (TME)**: The tumor microenvironment consists of immune cells, activated fibroblasts, and extracellular matrix, among which activated fibroblasts (CAFs) are key components. - **The Role of CAFs**: CAFs are mainly derived from resident fibroblasts, but can also be generated from bone marrow - derived mesenchymal cells through epithelial - mesenchymal transition (EMT). CAFs promote the proliferation, migration, and invasion of tumor cells by secreting growth factors, metalloproteinases (MMPs), etc. - **The Role of TRAF6**: TRAF6 is an important molecule involved in immunity, inflammation, bone metabolism, and development. Previous studies have shown that TRAF6 is highly expressed in melanoma and promotes the proliferation, invasion, and metastasis of melanoma cells. ### Research Objectives - **Explore the Role of TRAF6 in CAFs**: Investigate the expression of TRAF6 in melanoma - associated fibroblasts and its impact on fibroblast function. - **Reveal the Relationship between TRAF6 and FGF19**: Explore how TRAF6 affects fibroblast activation by regulating the expression of FGF19, and further affects the malignant phenotype of melanoma cells. - **Verify the Role of TRAF6/FGF19 Axis in Melanoma**: Verify the importance of the TRAF6/FGF19 axis in melanoma progression through in vivo and in vitro experiments, and provide new targets for melanoma treatment. ### Main Findings - **TRAF6 Promotes Fibroblast Activation**: Over - expression of TRAF6 significantly promotes the proliferation, migration, and expression of MMPs in fibroblasts, and these changes support the transformation of fibroblasts into CAFs. - **TRAF6 Affects Melanoma Cells through FGF19**: TRAF6 up - regulates the expression of FGF19 through the NF - κB1 pathway, and FGF19 further promotes fibroblast activation and enhances the malignant phenotype of melanoma cells. - **In Vivo Experiment Verification**: In a mouse xenograft model, fibroblasts over - expressing TRAF6 significantly promote the growth of melanoma cells, while inhibiting TRAF6 expression has the opposite effect. ### Conclusions - **The Role of TRAF6/FGF19 Axis in Melanoma**: TRAF6 promotes the transformation of fibroblasts into CAFs by up - regulating the expression of FGF19, thereby enhancing the malignant phenotype of melanoma cells. - **Potential Therapeutic Targets**: The TRAF6/FGF19 axis may become a new target for melanoma treatment. In summary, this study reveals the important role of TRAF6 in the melanoma microenvironment, especially by regulating the expression of FGF19 to affect fibroblast activation, thereby promoting the progression of melanoma. This finding provides a theoretical basis for the development of new melanoma treatment methods.